Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$4.90
-0.03-0.61%
At close: -
$4.80
-0.1-2.03%
After Hours: 6:38 PM EDT
Comments
Loading...
GoodRx Holdings Analyst Ratings and Price Targets | NASDAQ:GDRX | Benzinga
GoodRx Holdings Inc has a consensus price target of $8.06 based on the ratings of 25 analysts. The high is $16 issued by TD Cowen on May 16, 2024. The low is $4.5 issued by B of A Securities on January 2, 2024. The 3 most-recent analyst ratings were released by UBS, Goldman Sachs, and Wells Fargo on May 13, 2025, May 9, 2025, and April 29, 2025, respectively. With an average price target of $5.75 between UBS, Goldman Sachs, and Wells Fargo, there's an implied 19.78% upside for GoodRx Holdings Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
UBS
Goldman Sachs
Wells Fargo
Truist Securities
Citigroup
1calculated from analyst ratings
Analyst Ratings for GoodRx Holdings
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/13/2025 | Buy Now | 9.36% | UBS | Kevin Caliendo72% | $6 → $5.25 | Maintains | Neutral | Get Alert |
| 05/09/2025 | Buy Now | 4.15% | Goldman Sachs | Eric Sheridan78% | $6 → $5 | Maintains | Neutral | Get Alert |
| 04/29/2025 | Buy Now | 45.82% | Wells Fargo | Stan Berenshteyn46% | $8 → $7 | Maintains | Overweight | Get Alert |
| 04/10/2025 | Buy Now | 14.57% | Truist Securities | Jailendra Singh38% | $6.5 → $5.5 | Maintains | Hold | Get Alert |
| 02/28/2025 | Buy Now | 66.65% | Wells Fargo | Stan Berenshteyn46% | $9 → $8 | Maintains | Overweight | Get Alert |
| 01/10/2025 | Buy Now | 30.19% | Citigroup | Daniel Grosslight44% | $7 → $6.25 | Maintains | Buy | Get Alert |
| 01/08/2025 | Buy Now | 24.98% | Keybanc | Scott Schoenhaus50% | $7 → $6 | Maintains | Overweight | Get Alert |
| 12/17/2024 | Buy Now | 24.98% | Morgan Stanley | Craig Hettenbach58% | $7 → $6 | Maintains | Equal-Weight | Get Alert |
| 11/13/2024 | Buy Now | 45.82% | Citigroup | Daniel Grosslight44% | $10 → $7 | Maintains | Buy | Get Alert |
| 11/11/2024 | Buy Now | 24.98% | Barclays | Stephanie Davis42% | $10 → $6 | Maintains | Overweight | Get Alert |
| 08/16/2024 | Buy Now | 108.31% | RBC Capital | Sean Dodge47% | $10 → $10 | Reiterates | Outperform → Outperform | Get Alert |
| 08/09/2024 | Buy Now | 77.06% | UBS | Kevin Caliendo72% | $9 → $8.5 | Maintains | Neutral | Get Alert |
| 08/09/2024 | Buy Now | 108.31% | Citigroup | Daniel Grosslight44% | $11 → $10 | Maintains | Buy | Get Alert |
| 06/10/2024 | Buy Now | 97.89% | Morgan Stanley | Craig Hettenbach58% | $7 → $9.5 | Maintains | Equal-Weight | Get Alert |
| 05/23/2024 | Buy Now | 108.31% | RBC Capital | Mark Mahaney82% | $8 → $10 | Upgrade | Sector Perform → Outperform | Get Alert |
| 05/20/2024 | Buy Now | 108.31% | Barclays | Stephanie Davis42% | $9 → $10 | Maintains | Overweight | Get Alert |
| 05/16/2024 | Buy Now | 108.31% | Raymond James | John Ransom76% | → $10 | Upgrade | Market Perform → Outperform | Get Alert |
| 05/16/2024 | Buy Now | 233.29% | TD Cowen | Charles Rhyee38% | $14 → $16 | Maintains | Buy | Get Alert |
| 04/10/2024 | Buy Now | 87.48% | Keybanc | Scott Schoenhaus50% | → $9 | Upgrade | Sector Weight → Overweight | Get Alert |
| 03/25/2024 | Buy Now | 108.31% | Wells Fargo | Stan Berenshteyn46% | → $10 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 03/08/2024 | Buy Now | 66.65% | RBC Capital | Sean Dodge47% | $8 → $8 | Reiterates | Sector Perform → Sector Perform | Get Alert |
| 03/01/2024 | Buy Now | 66.65% | UBS | Kevin Caliendo72% | $5 → $8 | Maintains | Neutral | Get Alert |
| 03/01/2024 | Buy Now | 56.23% | Wells Fargo | Stan Berenshteyn46% | $6 → $7.5 | Maintains | Equal-Weight | Get Alert |
| 03/01/2024 | Buy Now | 66.65% | RBC Capital | Sean Dodge47% | $7 → $8 | Maintains | Sector Perform | Get Alert |
| 03/01/2024 | Buy Now | 56.23% | Goldman Sachs | Eric Sheridan78% | $6.5 → $7.5 | Maintains | Neutral | Get Alert |
| 03/01/2024 | Buy Now | 66.65% | Truist Securities | Jailendra Singh38% | $7.5 → $8 | Maintains | Hold | Get Alert |
| 03/01/2024 | Buy Now | 191.63% | TD Cowen | Charles Rhyee38% | $12 → $14 | Maintains | Outperform | Get Alert |
| 03/01/2024 | Buy Now | 108.31% | JP Morgan | Lisa Gill55% | $7 → $10 | Upgrade | Neutral → Overweight | Get Alert |
| 03/01/2024 | Buy Now | 87.48% | Barclays | Steve Valiquette52% | $8 → $9 | Maintains | Overweight | Get Alert |
| 02/26/2024 | Buy Now | 66.65% | Leerink Partners | Michael Cherny79% | → $8 | Initiates | → Outperform | Get Alert |
| 01/16/2024 | Buy Now | 45.82% | RBC Capital | Sean Dodge47% | $5 → $7 | Maintains | Sector Perform | Get Alert |
| 01/12/2024 | Buy Now | 56.23% | Truist Securities | Jailendra Singh38% | $5.5 → $7.5 | Maintains | Hold | Get Alert |
| 01/02/2024 | Buy Now | -6.26% | B of A Securities | Michael Cherny79% | $8 → $4.5 | Downgrade | Buy → Underperform | Get Alert |
| 11/17/2023 | Buy Now | 24.98% | JP Morgan | Doug Anmuth86% | $7 → $6 | Maintains | Neutral | Get Alert |
| 11/13/2023 | Buy Now | 24.98% | Goldman Sachs | Eric Sheridan78% | $7 → $6 | Maintains | Neutral | Get Alert |
| 11/10/2023 | Buy Now | 4.15% | RBC Capital | Sean Dodge47% | $8 → $5 | Maintains | Sector Perform | Get Alert |
| 11/10/2023 | Buy Now | 24.98% | Goldman Sachs | Eric Sheridan78% | $7 → $6 | Maintains | Neutral | Get Alert |
| 11/10/2023 | Buy Now | 14.57% | Truist Securities | Jailendra Singh38% | $8 → $5.5 | Maintains | Hold | Get Alert |
| 11/10/2023 | Buy Now | 14.57% | Morgan Stanley | Ricky Goldwasser78% | $8 → $5.5 | Maintains | Equal-Weight | Get Alert |
| 09/14/2023 | Buy Now | 45.82% | JP Morgan | Doug Anmuth86% | $6 → $7 | Maintains | Neutral | Get Alert |
| 08/11/2023 | Buy Now | 45.82% | Goldman Sachs | Eric Sheridan78% | $6.25 → $7 | Maintains | Neutral | Get Alert |
| 08/10/2023 | Buy Now | 66.65% | Deutsche Bank | George Hill60% | $6 → $8 | Maintains | Hold | Get Alert |
| 08/10/2023 | Buy Now | 108.31% | Guggenheim | Sandy Draper73% | $8 → $10 | Maintains | Buy | Get Alert |
| 08/10/2023 | Buy Now | 24.98% | JP Morgan | Doug Anmuth86% | $5 → $6 | Maintains | Neutral | Get Alert |
| 08/10/2023 | Buy Now | 129.14% | Citigroup | Daniel Grosslight44% | $7 → $11 | Maintains | Buy | Get Alert |
| 08/10/2023 | Buy Now | 108.31% | Evercore ISI Group | Mark Mahaney82% | $7 → $10 | Maintains | In-Line | Get Alert |
| 08/10/2023 | Buy Now | 45.82% | Goldman Sachs | Eric Sheridan78% | $6.25 → $7 | Maintains | Neutral | Get Alert |
| 08/10/2023 | Buy Now | 66.65% | Credit Suisse | Jonathan Yong65% | $7 → $8 | Maintains | Neutral | Get Alert |
| 08/10/2023 | Buy Now | 66.65% | RBC Capital | Sean Dodge47% | $6 → $8 | Maintains | Sector Perform | Get Alert |
| 08/10/2023 | Buy Now | 97.89% | DA Davidson | Robert Simmons56% | → $9.5 | Upgrade | Neutral → Buy | Get Alert |
| 08/10/2023 | Buy Now | 45.82% | Wells Fargo | Stan Berenshteyn46% | $6 → $7 | Maintains | Equal-Weight | Get Alert |
| 07/31/2023 | Buy Now | 149.97% | TD Cowen | Charles Rhyee38% | $6.5 → $12 | Upgrade | Market Perform → Outperform | Get Alert |
| 07/18/2023 | Buy Now | 45.82% | Truist Securities | Jailendra Singh38% | $6 → $7 | Maintains | Hold | Get Alert |
| 07/17/2023 | Buy Now | 66.65% | Morgan Stanley | Ricky Goldwasser78% | $6 → $8 | Maintains | Equal-Weight | Get Alert |
| 07/12/2023 | Buy Now | — | Keybanc | Scott Schoenhaus50% | — | Maintains | Sector Weight | Get Alert |
| 05/11/2023 | Buy Now | 66.65% | B of A Securities | Michael Cherny79% | $9 → $8 | Maintains | Buy | Get Alert |
| 05/11/2023 | Buy Now | 24.98% | RBC Capital | Sean Dodge47% | → $6 | Reiterates | Sector Perform → Sector Perform | Get Alert |
| 05/11/2023 | Buy Now | 30.19% | Goldman Sachs | Eric Sheridan78% | $7 → $6.25 | Maintains | Neutral | Get Alert |
| 05/11/2023 | Buy Now | 45.82% | Citigroup | Daniel Grosslight44% | $7.5 → $7 | Maintains | Buy | Get Alert |
| 03/08/2023 | Buy Now | 56.23% | Citigroup | Daniel Grosslight44% | $7 → $7.5 | Maintains | Buy | Get Alert |
| 03/07/2023 | Buy Now | 66.65% | Deutsche Bank | George Hill60% | $7 → $8 | Maintains | Hold | Get Alert |
| 03/02/2023 | Buy Now | 45.82% | Goldman Sachs | Eric Sheridan78% | $8 → $7 | Maintains | Neutral | Get Alert |
| 03/02/2023 | Buy Now | 66.65% | Credit Suisse | Jonathan Yong65% | $9 → $8 | Maintains | Neutral | Get Alert |
| 03/02/2023 | Buy Now | 24.98% | Wells Fargo | Stan Berenshteyn46% | $5.5 → $6 | Maintains | Equal-Weight | Get Alert |
| 03/01/2023 | Buy Now | 45.82% | Goldman Sachs | Eric Sheridan78% | $8 → $7 | Maintains | Neutral | Get Alert |
| 01/18/2023 | Buy Now | 66.65% | Barclays | Steve Valiquette52% | $9 → $8 | Maintains | Overweight | Get Alert |
| 12/01/2022 | Buy Now | 45.82% | Citigroup | Daniel Grosslight44% | → $7 | Initiates | → Buy | Get Alert |
| 11/09/2022 | Buy Now | 66.65% | Goldman Sachs | Eric Sheridan78% | $10 → $8 | Maintains | Neutral | Get Alert |
| 11/09/2022 | Buy Now | 24.98% | RBC Capital | Sean Dodge47% | $11 → $6 | Maintains | Sector Perform | Get Alert |
| 11/09/2022 | Buy Now | 24.98% | Morgan Stanley | Ricky Goldwasser78% | $10 → $6 | Maintains | Equal-Weight | Get Alert |
| 11/04/2022 | Buy Now | 66.65% | JP Morgan | Doug Anmuth86% | $10 → $8 | Upgrade | Underweight → Neutral | Get Alert |
| 10/11/2022 | Buy Now | 87.48% | Barclays | Ross Sandler71% | $13 → $9 | Maintains | Overweight | Get Alert |
| 09/16/2022 | Buy Now | — | Keybanc | Scott Schoenhaus50% | — | Initiates | → Sector Weight | Get Alert |
| 09/07/2022 | Buy Now | 35.4% | Truist Securities | Jailendra Singh38% | → $6.5 | Initiates | → Hold | Get Alert |
| 08/12/2022 | Buy Now | 66.65% | DA Davidson | Robert Simmons56% | → $8 | Initiates | → Neutral | Get Alert |
| 08/10/2022 | Buy Now | 108.31% | Morgan Stanley | Ricky Goldwasser78% | $10.5 → $10 | Maintains | Equal-Weight | Get Alert |
| 08/09/2022 | Buy Now | 129.14% | Credit Suisse | Jonathan Yong65% | $10 → $11 | Maintains | Neutral | Get Alert |
| 08/09/2022 | Buy Now | 108.31% | Goldman Sachs | Eric Sheridan78% | $9 → $10 | Maintains | Neutral | Get Alert |
| 08/09/2022 | Buy Now | 129.14% | RBC Capital | Sean Dodge47% | $6.5 → $11 | Maintains | Sector Perform | Get Alert |
| 08/09/2022 | Buy Now | 170.8% | Barclays | Steve Valiquette52% | $12 → $13 | Maintains | Overweight | Get Alert |
| 08/09/2022 | Buy Now | 129.14% | SVB Leerink | Stephanie Davis42% | $8 → $11 | Maintains | Market Perform | Get Alert |
| 07/20/2022 | Buy Now | 149.97% | Barclays | Steve Valiquette52% | $15 → $12 | Maintains | Overweight | Get Alert |
| 07/18/2022 | Buy Now | 170.8% | Guggenheim | Sandy Draper73% | $17 → $13 | Maintains | Buy | Get Alert |
FAQ
What is the target price for GoodRx Holdings (GDRX) stock?
The latest price target for GoodRx Holdings (NASDAQ:GDRX) was reported by UBS on May 13, 2025. The analyst firm set a price target for $5.25 expecting GDRX to rise to within 12 months (a possible 9.36% upside). 13 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for GoodRx Holdings (GDRX)?
The latest analyst rating for GoodRx Holdings (NASDAQ:GDRX) was provided by UBS, and GoodRx Holdings maintained their neutral rating.
When was the last upgrade for GoodRx Holdings (GDRX)?
The last upgrade for GoodRx Holdings Inc happened on May 23, 2024 when RBC Capital raised their price target to $10. RBC Capital previously had a sector perform for GoodRx Holdings Inc.
When was the last downgrade for GoodRx Holdings (GDRX)?
The last downgrade for GoodRx Holdings Inc happened on January 2, 2024 when B of A Securities changed their price target from $8 to $4.5 for GoodRx Holdings Inc.
When is the next analyst rating going to be posted or updated for GoodRx Holdings (GDRX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of GoodRx Holdings, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for GoodRx Holdings was filed on May 13, 2025 so you should expect the next rating to be made available sometime around May 13, 2026.
Is the Analyst Rating GoodRx Holdings (GDRX) correct?
While ratings are subjective and will change, the latest GoodRx Holdings (GDRX) rating was a maintained with a price target of $6.00 to $5.25. The current price GoodRx Holdings (GDRX) is trading at is $4.80, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
